Clinical comprehensive evaluation of CDK4/6 inhibitor combined with fulvestrant in HR+/HER2-advanced breast cancer patients

doi:10.3969/j.issn.1672-3384.2024.Z1.011

Keming CAO, Wei CHEN, Rongguo SHANG, Jingxin WANG, Jingbo SUN, Wenxin XUE

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (Z1) : 74-80.

PDF(471 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (Z1) : 74-80. DOI: 10.3969/j.issn.1672-3384.2024.Z1.011

Original Article

Clinical comprehensive evaluation of CDK4/6 inhibitor combined with fulvestrant in HR+/HER2-advanced breast cancer patients

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(Z1): 74-80 https://doi.org/10.3969/j.issn.1672-3384.2024.Z1.011

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(471 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export